ANTICOAGULANT MONITORING
PICT
CLOTTING ASSAY

PEFAKIT® PICT® CONTROLS LMWH

Cat Num. Conditioning  
8-505-213 x 2 x 1,0 mL
Control plasmas for the quantification of low molecular weight heparins (LMWH) with Pefakit® PiCT®
Pefakit® PiCT® Controls LMWH contains vials of plasma with low and high LMWH anticoagulant activity (C1, C2).

Kit contents:

  • 3 vials of LMWH Control 1 (1mL)
  • 3 vials of LMWH Control 2 (1 mL)
Characteristics
Traditional coagulation tests such as aPTT, PT, ECT, TT or anti-Xa assays are of limited use for the monitoring of antithrombotic drugs since different assays are required for monitoring of different anticoagulants.
The most commonly used test, aPTT, broadly used to monitor heparin, lacks consistency, results varying with reagent, instrument and drug.
Chromogenic assays represent the gold standard in most cases, but require special instrumentation.
A universal test adaptable to standard instruments would simplify monitoring antithrombotic therapy and minimize investment to the hemostasis lab by eliminating the need for adopting new tests as new antithrombotic drugs enter the market.

THEY TRUST US

OUR PARTNERS